112 results
D
ACST
Acasti Pharma Inc - Ordinary Shares
10 Oct 23
$15.12 mm in equity / options / securities to be acquired, sold $7.50 mm, 4 investors
7:40am
, States cannot
routinely require offering materials under this undertaking or otherwise and can require offering materials only to the
extent NSMIA permits them to do so under NSMIA's preservation of their anti-fraud authority.
8-K
EX-10.1
71k1xhvdz6
26 Sep 23
Acasti Announces $7.5 Million Private Placement Equity Financing
8:10am
DEFA14A
ivmnisyupx
25 Aug 23
Additional proxy soliciting materials
4:21pm
8-K
co4e43v3vhuag iib
29 Jul 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:01pm
424B5
33yrzbp b7xa78z2ru
10 Nov 21
Prospectus supplement for primary offering
7:23am
425
EX-99.1
49496j81
12 Aug 21
Business combination disclosure
11:00am